Maitreya Medicare Ltd.
•₹ 118.50%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 24.6%
- Company has a healthy return on capital (ROCE) of 20.5%
- Working capital cycle has improved - days down from 110 to 71
- Company maintains a comfortable, low leverage position
CONS
- Receivables are growing faster than sales - a possible quality concern
- Stock is trading at 7.7x its book value
- Debtor days have increased from 88 to 116
- Rich enterprise valuation - EV/EBITDA of 40.2x
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | APOLLOHOSP | 8799.00 | 60.55 | 126516.12 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| 2. | MANIPALHOS | 744.55 | 109.75 | 97936.41 | 0.00 | — | — | — | — | 13.93 | — |
| 3. | MAXHEALTH | 996.45 | 66.57 | 96982.14 | 0.20 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| 4. | ASTERDM | 800.70 | 219.01 | 69794.81 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| 5. | FORTIS | 910.80 | 65.62 | 68761.59 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| 6. | MEDANTA | 1419.05 | 68.60 | 38154.25 | 0.04 | 157.25 | -1.09 | 1304.05 | 26.50 | 20.50 | 21.99 |
| 7. | NH | 1782.70 | 44.64 | 36431.40 | 0.25 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| 8. | KIMS | 788.60 | 162.12 | 33121.71 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| 9. | LALPATHLAB | 1886.80 | 58.44 | 31669.72 | 1.09 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| 10. | AGARWALEYE | 499.70 | 106.77 | 15841.80 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 14.32 | 27.75 |
| 11. | VIJAYA | 1489.70 | 81.84 | 15343.57 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.27 | 42.66 |
| 12. | MAITREYA | 111.00 | 0.00 | 75.21 | 0.00 | -1.07 | — | 12.32 | 43.42 | 10.96 | -7.55 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2022 | Mar 2023 | Dec 2023 | Mar 2024 | |
|---|---|---|---|---|
| 9 | 10 | 12 | 11 | |
| 8 | 8 | 9 | 11 | |
| Operating Profit | — | — | — | — |
| OPM % | — | — | — | — |
| Other Income | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 |
| 0 | 3 | 2 | -1 | |
| Tax % | 30.77% | 31.15% | 24.53% | 24.58% |
| Net Profit | 0 | 2 | 2 | -1 |
| 0 | 0 | 3 | 0 | |
| Equity Capital | 0 | 5 | 7 | 7 |
| Reserves | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 0 | 5 | 7 | 7 |
| Reserves | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% |
Dec 2022
- 9
- 8
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 30.77%
- Net Profit
- 0
- 0
- Equity Capital
- 0
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 0
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2023
- 10
- 8
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 3
- Tax %
- 31.15%
- Net Profit
- 2
- 0
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 12
- 9
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 2
- Tax %
- 24.53%
- Net Profit
- 2
- 3
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 11
- 11
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- -1
- Tax %
- 24.58%
- Net Profit
- -1
- 0
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|
| 38 | 47 | 44 | 41 | |
| 31 | 40 | 40 | 36 | |
| Operating Profit | 8 | 6 | 5 | — |
| OPM % | 20 | 14 | 12 | — |
| Other Income | 1 | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 |
| 6 | 4 | 3 | 4 | |
| Tax % | 28 | 28 | 41 | 29 |
| Net Profit | 4 | 3 | 2 | 3 |
| EPS | 7 | 4 | 3 | — |
| Dividend Payout % | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 |
| Adjusted EPS | 8 | 4 | 3 | — |
| Minority Interest | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 |
| Adjusted EPS | 8 | 4 | 3 | — |
Mar 2023
- 38
- 31
- Operating Profit
- 8
- OPM %
- 20
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 6
- Tax %
- 28
- Net Profit
- 4
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
Mar 2024
- 47
- 40
- Operating Profit
- 6
- OPM %
- 14
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 4
- Tax %
- 28
- Net Profit
- 3
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2025
- 44
- 40
- Operating Profit
- 5
- OPM %
- 12
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 3
- Tax %
- 41
- Net Profit
- 2
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
TTM
- 41
- 36
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 4
- Tax %
- 29
- Net Profit
- 3
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -54%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 25%
- Last Year:
- 7%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| 5 | 7 | 7 | |
| 4 | 18 | 20 | |
| 1 | 1 | 2 | |
| Trade Payables | 4 | 2 | 3 |
| 14 | 12 | 13 | |
| Total Liabilities | 28 | 41 | 44 |
| ASSETS | - | - | - |
| 12 | 11 | 12 | |
| 1 | 4 | 8 | |
| 1 | 0 | 0 | |
| 0 | 13 | 15 | |
| Cash & Bank | 1 | 6 | 2 |
| 13 | 7 | 7 | |
| Total Assets | 28 | 41 | 44 |
| Total Debt | 6 | 4 | 4 |
| Net Working Capital | 5 | 14 | 9 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | 17.71 | 36.69 | 39.49 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Total Debt | 6 | 4 | 4 |
| Net Working Capital | 5 | 14 | 9 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | 17.71 | 36.69 | 39.49 |
| Face Value | 10.00 | 10.00 | 10.00 |
Mar 2023
- 5
- 4
- 1
- Trade Payables
- 4
- 14
- Total Liabilities
- 28
- 12
- 1
- 1
- 0
- Cash & Bank
- 1
- 13
- Total Assets
- 28
- Total Debt
- 6
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 17.71
- Face Value
- 10.00
- Total Debt
- 6
- Net Working Capital
- 5
- Contingent Liabilities
- 0
- Book Value per Share
- 17.71
- Face Value
- 10.00
Mar 2024
- 7
- 18
- 1
- Trade Payables
- 2
- 12
- Total Liabilities
- 41
- 11
- 4
- 0
- 13
- Cash & Bank
- 6
- 7
- Total Assets
- 41
- Total Debt
- 4
- Net Working Capital
- 14
- Contingent Liabilities
- 0
- Book Value per Share
- 36.69
- Face Value
- 10.00
- Total Debt
- 4
- Net Working Capital
- 14
- Contingent Liabilities
- 0
- Book Value per Share
- 36.69
- Face Value
- 10.00
Mar 2025
- 7
- 20
- 2
- Trade Payables
- 3
- 13
- Total Liabilities
- 44
- 12
- 8
- 0
- 15
- Cash & Bank
- 2
- 7
- Total Assets
- 44
- Total Debt
- 4
- Net Working Capital
- 9
- Contingent Liabilities
- 0
- Book Value per Share
- 39.49
- Face Value
- 10.00
- Total Debt
- 4
- Net Working Capital
- 9
- Contingent Liabilities
- 0
- Book Value per Share
- 39.49
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 2 | -0 | 5 | |
| Cash from Investing | 0 | -6 | -7 |
| Cash from Financing | -1 | 10 | -2 |
| 1 | 4 | -4 | |
| Free Cash Flow | 2 | -1 | 3 |
| OCF / Net Profit | 0.58 | -0.08 | 2.65 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | 0.58 | -0.08 | 2.65 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
Mar 2023
- 2
- Cash from Investing
- 0
- Cash from Financing
- -1
- 1
- Free Cash Flow
- 2
- OCF / Net Profit
- 0.58
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.58
- Cumulative 5-Year FCF
- 0
Mar 2024
- -0
- Cash from Investing
- -6
- Cash from Financing
- 10
- 4
- Free Cash Flow
- -1
- OCF / Net Profit
- -0.08
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.08
- Cumulative 5-Year FCF
- 0
Mar 2025
- 5
- Cash from Investing
- -7
- Cash from Financing
- -2
- -4
- Free Cash Flow
- 3
- OCF / Net Profit
- 2.65
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.65
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | 7.84 | 4.16 | 2.80 |
| Book Value (₹) | 17.71 | 36.69 | 39.49 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 11.00 | 6.54 | 4.79 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 20.03% | 13.24% | 10.99% |
| Net Margin % | 10.88% | 6.82% | 4.28% |
| ROE % | 47.66% | 18.87% | 7.36% |
| ROCE % | 31.45% | 18.75% | 11.37% |
| 15.08% | 9.30% | 4.47% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 88 | 88 | 116 |
| Inventory Days | 8 | 5 | 4 |
| Payable Days | 275 | 167 | 145 |
| -179 | -74 | -25 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | 0.40x | 0.13x | 0.11x |
| Interest Coverage (x) | 11.29x | 6.94x | 5.27x |
| 1.57x | 3.05x | 1.90x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | 20.92% | -4.55% |
| Operating Profit Growth % | 0.00% | -17.20% | -16.61% |
| Net Profit Growth % | 0.00% | -24.18% | -40.15% |
| 0.00% | -46.99% | -32.59% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 28.62x | 109.01x |
| P/B (x) | 0.00x | 3.24x | 7.74x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 13.23x | 40.20x |
Mar 2023
- EPS (₹)
- 7.84
- Book Value (₹)
- 17.71
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 11.00
- Operating Margin %
- 20.03%
- Net Margin %
- 10.88%
- ROE %
- 47.66%
- ROCE %
- 31.45%
- 15.08%
- Debtor Days
- 88
- Inventory Days
- 8
- Payable Days
- 275
- -179
- Debt to Equity (x)
- 0.40x
- Interest Coverage (x)
- 11.29x
- 1.57x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 4.16
- Book Value (₹)
- 36.69
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.54
- Operating Margin %
- 13.24%
- Net Margin %
- 6.82%
- ROE %
- 18.87%
- ROCE %
- 18.75%
- 9.30%
- Debtor Days
- 88
- Inventory Days
- 5
- Payable Days
- 167
- -74
- Debt to Equity (x)
- 0.13x
- Interest Coverage (x)
- 6.94x
- 3.05x
- Revenue Growth %
- 20.92%
- Operating Profit Growth %
- -17.20%
- Net Profit Growth %
- -24.18%
- -46.99%
- P/E (x)
- 28.62x
- P/B (x)
- 3.24x
- Dividend Yield %
- 0.00%
- 13.23x
Mar 2025
- EPS (₹)
- 2.80
- Book Value (₹)
- 39.49
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.79
- Operating Margin %
- 10.99%
- Net Margin %
- 4.28%
- ROE %
- 7.36%
- ROCE %
- 11.37%
- 4.47%
- Debtor Days
- 116
- Inventory Days
- 4
- Payable Days
- 145
- -25
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- 5.27x
- 1.90x
- Revenue Growth %
- -4.55%
- Operating Profit Growth %
- -16.61%
- Net Profit Growth %
- -40.15%
- -32.59%
- P/E (x)
- 109.01x
- P/B (x)
- 7.74x
- Dividend Yield %
- 0.00%
- 40.20x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nov 2025
Sep 2025
Nov 2024